Target intelligence / Profile preview

Parasite cell membrane phospholipid metabolism

Molecular classification
Enzyme (for individual components like PfCEPT and PfPSS), Other (refers to a metabolic process/pathway)
01

Overview

Parasite cell membrane phospholipid metabolism refers to the network of biochemical pathways responsible for synthesizing and remodeling the major structural lipids that compose protozoan parasite membranes—including those of malaria parasites such as Plasmodium falciparum. These processes are essential for rapid proliferation inside host erythrocytes because they support expansion and maintenance of both plasma and internal organelle membranes during replication cycles. While some lipids can be scavenged from the host environment, most pathogenic protozoa—including Plasmodium—rely heavily on de novo biosynthesis using unique enzymatic machinery not found in humans or with significant differences from human homologues. Key steps include fatty acid synthesis followed by assembly into complex glycerophospholipids via pathways like Kennedy’s pathway; critical products include phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylserine (PS). Enzymes such as CDP-choline/ethanolamine-phosphotransferase (PfCEPT) and prokaryote-type PS synthase (PfPSS) have been identified as essential components unique to parasites. These metabolic activities not only provide structural material but also play roles in protein trafficking, signal transduction, immune evasion mechanisms, nutrient acquisition from hosts, modulation of host cell membranes during invasion events, and adaptation to environmental stresses within different life cycle stages. Because these processes differ significantly between parasites and their mammalian hosts—and because they are indispensable for survival—they represent attractive targets for novel antiparasitic drug development efforts aimed at treating diseases like malaria without harming human cells.[1][2][3][4][5]

Other names
Parasite phospholipid biosynthesisPlasmodium phospholipid metabolismMalaria parasite lipid synthesisPhospholipid metabolic pathway in parasites
02

Mechanism of action

Drugs targeting this process typically act by inhibiting essential enzymes involved in de novo synthesis of major membrane phospholipids—such as blocking the formation of phosphatidylcholine or interfering with precursor uptake—thereby compromising parasite membrane integrity and survival during intraerythrocytic development[2][5].

03

Biological functions

Membrane biogenesis and integrityHost cell invasionNutrient acquisitionImmune evasion
04

Disease associations

Infection (notably malaria caused by Plasmodium species)
05

Safety considerations

Potential safety concerns include off-target effects on host lipid metabolism if inhibitors lack sufficient selectivity for parasite-specific enzymes versus human homologues.Disruption of host erythrocyte membranes is also a theoretical risk if selectivity is poor; however, many targeted enzymes have significant structural differences from mammalian counterparts which may mitigate these risks[2].
06

Interacting drugs

Specific drugs targeting the overall process are under investigation; examples include experimental inhibitors of key enzymes such as choline analogs that inhibit CDP-choline/ethanolamine phosphotransferase activity. No approved drugs directly target the entire pathway yet, but several compounds are being studied for their ability to disrupt parasite-specific lipid synthesis pathways[2].
07

Biomarkers

No established clinical biomarkers for patient selection or efficacy monitoring specific to this pathway. Research use may involve tracking labeled precursors incorporated into parasite membranes or measuring levels of key lipids/phospholipids in infected cells for experimental purposes[1][5].

Beyond the preview

Go deeper on Parasite cell membrane phospholipid metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parasite cell membrane phospholipid metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call